XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2021
Fair Value Measurements  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

Assets and liabilities measured at fair value are summarized below:

 

   Total Fair Value   Quoted Prices in Active Markets for Identical Assets/Liabilities (Level 1)  

Significant Other Observable Inputs

(Level 2)

  

Significant Unobservable Inputs

(Level 3)

 
Assets:                    
                     
Recurring items as of September 30, 2021                    
Investment in debt securities - available for sale, at fair value  $28,864,364   $   $28,864,364   $ 
                     
Non-recurring items as of September 30, 2021                    
In-process R&D (Note 9)  $13,366,234   $   $   $13,366,234 
                     
Non-recurring items as of December 31, 2020                    
In-process R&D (Note 9)  $13,366,234   $   $   $13,366,234 
                     
Liabilities:                    
                     
Recurring items as of September 30, 2021                    
Earn-out milestone liability (Note 14)  $7,345,000   $   $   $7,345,000 
                     
Recurring items as of December 31, 2020                    
Earn-out milestone liability (Note 14)  $7,018,000   $   $   $7,018,000